SINH.N0000 Share Price | Singhe Hospitals PLC Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Compare Singhe Hospitals PLC with Similar Stocks

Lanka Hospitals Corp. Plc Asiri Hospital Holdings PLC Asiri Surgical Hospital Plc

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.19 times

Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.19 times
The company has been able to generate a Return on Equity (avg) of 3.82% signifying low profitability per unit of shareholders funds

With a growth in Net Profit of 45.36%, the company declared Very Positive results in Dec 25

With ROE of 16.73%, it has a very expensive valuation with a 4.77 Price to Book Value

Market Beating performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Hospital

Market cap

LKR 9,273 Million (Small Cap)

P/E

29.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.02

Return on Equity

21.39%

Price to Book

8.59

Revenue and Profits:

Net Sales:

502 Million

(Quarterly Results - Dec 2025)

Net Profit:

66 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

113.73%

6 Months

162.65%

1 Year

678.57%

2 Years

847.83%

3 Years

738.46%

4 Years

651.72%

5 Years

990.0%

Singhe Hospitals PLC for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

23.05%

EBIT Growth (5y)

54.02%

EBIT to Interest (avg)

3.58

Debt to EBITDA (avg)

1.19

Net Debt to Equity (avg)

0.09

Sales to Capital Employed (avg)

1.39

Tax Ratio

20.95%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

17.85%

ROE (avg)

3.82%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.77

EV to EBIT

13.06

EV to EBITDA

10.41

EV to Capital Employed

4.67

EV to Sales

2.85

PEG Ratio

0.07

Dividend Yield

ROCE (Latest)

35.71%

ROE (Latest)

16.73%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 6.08% vs 1.50% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 45.51% vs -17.06% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "502.40",
          "val2": "473.60",
          "chgp": "6.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "161.70",
          "val2": "130.30",
          "chgp": "24.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.80",
          "val2": "7.20",
          "chgp": "8.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "66.50",
          "val2": "45.70",
          "chgp": "45.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "279.70%",
          "val2": "227.40%",
          "chgp": "5.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 18.42% vs 18.72% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 372.36% vs 293.70% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,506.70",
          "val2": "1,272.30",
          "chgp": "18.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "269.10",
          "val2": "161.80",
          "chgp": "66.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "39.60",
          "val2": "57.40",
          "chgp": "-31.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "116.20",
          "val2": "24.60",
          "chgp": "372.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.30%",
          "val2": "69.20%",
          "chgp": "5.21%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

502.40

473.60

6.08%

Operating Profit (PBDIT) excl Other Income

161.70

130.30

24.10%

Interest

7.80

7.20

8.33%

Exceptional Items

0.00

Consolidate Net Profit

66.50

45.70

45.51%

Operating Profit Margin (Excl OI)

279.70%

227.40%

5.23%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 6.08% vs 1.50% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 45.51% vs -17.06% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

1,506.70

1,272.30

18.42%

Operating Profit (PBDIT) excl Other Income

269.10

161.80

66.32%

Interest

39.60

57.40

-31.01%

Exceptional Items

0.00

Consolidate Net Profit

116.20

24.60

372.36%

Operating Profit Margin (Excl OI)

121.30%

69.20%

5.21%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 18.42% vs 18.72% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 372.36% vs 293.70% in Mar 2024

All Annual Results

Company CV

About Singhe Hospitals PLC

Singhe Hospitals PLC

Hospital

Singhe Hospitals PLC is a private hospital engaged in providing laboratory and other related services. The Company is a tertiary care hospital with approximately 50 beds to accommodate patients with a range of medical specialties available across the day. It offers various services, which include around the clock outpatient department service, multi specialist consultants, around the clock radiology facility, around the clock pharmacy, intensive care unit, around the clock laboratory, dental unit, cardiac unit, around the clock ambulance service, ultrasound scanning, emergency treatment unit and patient parking facility. Its cardiac unit is equipped to diagnose cardiac anomalies. It also performs cataract and other eye surgeries. Its emergency unit consists of the ambulance, home nursing unit, emergency treatment unit and the intensive care unit. The Company has an endoscopy system, which can produce clear images for diagnosis of the patient. It operates in Ratnapura district.

Company Coordinates

Company Details

No 362, Colombo Road Ratnapura , None : 70000

Tel: 94 45 2232232

https://www.singhehospital.com/

Registrar Details